- Slimming aid from a southern African cactus set to be developed by UK firm Phytopharm and Unilever
- Production of the Hoodia cactus at Phytopharm's nursery in South Africa will rise
- Phytopharm will receive initial fee from Unilever, as well as future royalties
- Firm had initially hoped to market slimming drug from Hoodia with Pfizer
- Unilever will help develop snacks containing Hoodia extract
